MiNK Therapeutics, Inc.
INKT
$14.72
-$0.44-2.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.45% | 54.88% | 64.69% | 56.40% | 32.94% |
| Total Depreciation and Amortization | -5.58% | 0.56% | 17.01% | -13.10% | 17.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.43% | -36.19% | -226.80% | -29.42% | -35.24% |
| Change in Net Operating Assets | -4.80% | -101.69% | 29.91% | -105.84% | 75.96% |
| Cash from Operations | 47.25% | 43.09% | 28.85% | 44.82% | 41.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.30% | -- | 126.67% | 26,292.27% | -84.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.99% | -- | 126.67% | 7,770.15% | 1,597.28% |
| Foreign Exchange rate Adjustments | 87.84% | -646.51% | -54.24% | -211.48% | 49.49% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.78% | 42.24% | 29.31% | 181.89% | 151.65% |